Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Apr 5, 2019
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-03-28$3.89/sh+197,234$766,747→ 1,095,054 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (2)
- [F1]Effective as of March 28, 2019, an aggregate amount of $766,750 of principal and accrued interest in convertible promissory notes issued to RGD Investissements (the "Notes") converted in accordance with their terms into 197,234 shares of the Issuer's common stock.
- [F2]The conversion price of the Notes was calculated using the VWAP (as defined in the Notes) average of the last 30 days before March 28, 2019.